Decreased iKIR-HLA C Pair Confers Worse Clinical Outcomes for Patients With Myeloid Disease Receiving Antithymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with malignant hematologic diseases. Killer immunoglobin-like receptor (KIR) expressed by NK cells is closely associated with the transplant outcomes, and it has been widely explored and debated for a few decades. Rece...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: Zhao, Yanmin, Gao, Fei, Wu, Yibo, Shi, Jimin, Luo, Yi, Tan, Yamin, Yu, Jian, Lai, Xiaoyu, Zhang, Mingming, Zhang, Wei, Huang, He
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7901980/
https://ncbi.nlm.nih.gov/pubmed/33633734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.614488
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki